TrialThe Journal of infectious diseases2020

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children.

Elizabeth J McFarland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.